As an experienced pharmaceutical litigator, I am concerned over the safety and well-being of millions of Americans as a vaccine for COVID-19 is made available. It is vital that such a preventive cure become approved and adapted by Americans. But the urgent need for creating one cannot disrupt or alter the safe scientific methods of clinical trials for ensuring a vaccine is safe.
The COVID-19 vaccine is the first of its kind. The conventional development milestones for new vaccines typically span 10-15 years; however, the coronavirus public health emergency has compressed this timeline. Many of the development stages overlapped and happened simultaneously. The United States Federal Food, Drug, and Cosmetic Act (FD&C) gives the FDA substantial authority to expedite the development and review of life-saving biologics.
COVID-19 aside, too many Americans suffer, are disabled, and die from defective medications.
I have prepared the new consumer brief, Protecting Yourself from Defective Drug Risks During the Age of COVID-19, in memory of those, and the many others who do not know if their lives and livelihoods are at risk because of medicine or medical treatment they are receiving. Please share it with everyone you care about.
